Exabis Library
Welcome to the e-CCO Library!
P288: Vedolizumab May Be An Effective Option For The Management Of Postoperative Recurrence Of Crohn’s Disease
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P289 Biological therapies and the trajectories of biopsychological factors in inflammatory bowel diseases
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P289: A French nationwide prospective study on patients with Crohn’s disease and ulcerative colitis treated with Infliximab-biosimilar CT-P13 in a real-life setting: two-year follow-up of the ReFLECT study
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P289: Cytomegalovirus reactivation in ulcerative colitis is related to severe inflammatory activity
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P289: Evaluation of the safety and effectiveness of direct-acting antiviral drugs in the treatment of hepatitis C in patients with inflammatory bowel disease: National multicenter study (ENEIDA registry). MIC project.
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P289: Hyperoxaluria in patients after ileocolic resection
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P289: Outcome of endoscopic ally resected dysplasic lesions in ulcerative colitis
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P289: The initial development of a Chat-Bot for inflammatory bowel disease (IBD) patients for use in e-health applications
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P289: Transcutaneous nonlinearity strain ultrasound differentiates early vs. advanced fibrotic intestine in vivo in the TNBS rat model and is feasible in patients with Crohn’s disease
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P290 Long-term disease outcome of ulcerative colitis (UC) in South Ostrobothnia, Finland with a follow-up time of 25 years
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P290: Compliance to vaccination guidelines in patients with immune-mediated inflammatory diseases: a cross-sectional, single-centre study
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P290: Determination of small-bowel patency in Crohn’s disease - a prospective study
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P290: Development of an artificial intelligence model using stool pictures for predicting endoscopic mucosal inflammation in patients with Ulcerative Colitis; KASID multicenter study
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P290: Evaluation of patients with retained patency capsule
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P290: Impact of concomitant 5-aminosalicylic acid therapy on vedolizumab efficacy and safety in Inflammatory Bowel Disease
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P290: Pre-operative anti-glycan antibodies and anti-glycan antibodies developing after pouch surgery in patients with ulcerative colitis correlate with pouch complications: a prospective longitudinal case series
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P290: Therapeutic requirements in patients with Ulcerative Proctitis. Is it necessary immunosuppressive therapy in these patients?
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P291 Diagnostic utility of the neutrophil-platelet rate (NeuPla) as a marker of activity in patients with ulcerative colitis
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P291: Can the prognostic index be a predicting factor for mortality and morbidity in intestinal resection of patients with ulcerative colitis?
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P291: Effect of the preconception steroid-free remission period on disease activity during pregnancy and birth outcomes in women with Ulcerative Colitis: a retrospective cohort study
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM